ABBVIE INC (ABBV) Stock News

Got $1,500? 3 Healthcare Stocks to Buy and Hold Forever

Evolus, An AbbVie And Botox Rival, Just Hit The Stratosphere — Here's Why

The company expects to soon expand from a single-product player to a "multi-product innovator."

See Which Of The Latest 13F Filers Holds AbbVie

Got $500? 2 Pharmaceutical Stocks to Buy and Hold Forever

Deal Dispatch: Biden Punts TikTok Ban To Trump, Plus Another Legacy Retailer Goes Bankrupt

Deal opportunities abound: KKR & Co.'s stake in Maya; DuPont's electronics business; Ingevity's North Charleston site; and S&W Seed Company.

Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations

HHS adds 15 drugs to Medicare Part D price negotiations, targeting cost reductions under the Inflation Reduction Act. New prices aim to save billions by 2027.

What's going on in today's session: S&P500 movers

Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Wednesday as we examine the latest happenings in today's session.

April 17th Options Now Available For AbbVie (ABBV)

Curious about the S&P500 stocks that are gapping on Wednesday? Explore the gap up and gap down stocks in the S&P500 index during today's session.

These S&P500 stocks are gapping in today's session

Simcere Zaiming and AbbVie Announce Partnership to Develop a Novel Trispecific Antibody Candidate in Multiple Myeloma

/PRNewswire/ -- Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group Ltd (HKEX: 2096) and AbbVie Inc. (NYSE: ABBV) today announced an option to...

AbbVie and REGENXBIO Announce Updates on the ABBV-RGX-314 Clinical Program

/PRNewswire/ -- AbbVie (NYSE: ABBV) and REGENXBIO Inc. (Nasdaq: RGNX) today announced updates to the ABBV-RGX-314 clinical program. ABBV-RGX-314 in Wet...

CoolMonth is Back With Deals on CoolSculpting® Elite by Allergan Aesthetics

/PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced its third annual CoolMonth featuring CoolSculpting® Elite. The celebration is an...

AbbVie to Host Full-Year and Fourth-Quarter 2024 Earnings Conference Call

/PRNewswire/ -- AbbVie (NYSE: ABBV) will announce its full-year and fourth-quarter 2024 financial results on Friday, January 31, 2025, before the market opens....

Achievements and Progress Heading into 2025 for Oncology Treatments and Therapies Fuel an Optimistic Outlook

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:GSK),(NASDAQ:AZN),(NYSE:ABBV),(NASDAQ:CRDF) EQNX::TICKER_END

Achievements and Progress Heading into 2025 for Oncology Treatments and Therapies Fuel an Optimistic Outlook